# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-270437
Filing Date
2019-10-21
Accepted
2019-10-21 08:06:25
Documents
141
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | d759444d20f.htm | 20-F | 1564164
2 | EX-4.12 | d759444dex412.htm | EX-4.12 | 106035
3 | EX-4.13 | d759444dex413.htm | EX-4.13 | 154879
4 | EX-4.14 | d759444dex414.htm | EX-4.14 | 411086
5 | EX-12.1 | d759444dex121.htm | EX-12.1 | 10405
6 | EX-12.2 | d759444dex122.htm | EX-12.2 | 10724
7 | EX-13.1 | d759444dex131.htm | EX-13.1 | 6125
8 | EX-23.1 | d759444dex231.htm | EX-23.1 | 2110
15 | GRAPHIC | g759444page_2.jpg | GRAPHIC | 6070
| Complete submission text file | 0001193125-19-270437.txt |  | 10080217

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | kzia-20190630.xml | EX-101.INS | 2333377
10 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20190630.xsd | EX-101.SCH | 111841
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | kzia-20190630_cal.xml | EX-101.CAL | 114330
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | kzia-20190630_def.xml | EX-101.DEF | 324849
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kzia-20190630_lab.xml | EX-101.LAB | 622818
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kzia-20190630_pre.xml | EX-101.PRE | 514997

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 191158797
SIC: 2834 Pharmaceutical Preparations